|
1
|
Morton LM, Dores GM, Schonfeld SJ, Linet
MS, Sigel BS, Lam CJK, Tucker MA and Curtis RE: Association of
chemotherapy for solid tumors with development of therapy-related
myelodysplastic syndrome or acute myeloid leukemia in the modern
era. JAMA Oncol. 5:318–325. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hulegårdh E, Nilsson C, Lazarevic V,
Garelius H, Antunovic P, Rangert Derolf Å, Möllgård L, Uggla B,
Wennström L, Wahlin A, et al: Characterization and prognostic
features of secondary acute myeloid leukemia in a population-based
setting: A report from the Swedish acute leukemia registry. Am J
Hematol. 90:208–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheung E, Perissinotti AJ, Bixby DL, Burke
PW, Pettit KM, Benitez LL, Brown J, Scappaticci GB and Marini BL:
The leukemia strikes back: A review of pathogenesis and treatment
of secondary AML. Ann Hematol. 98:541–559. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Granfeldt Østgård LS, Medeiros BC,
Sengeløv H, Nørgaard M, Andersen MK, Dufva IH, Friis LS, Kjeldsen
E, Marcher CW, Preiss B, et al: Epidemiology and clinical
significance of secondary and therapy-related acute myeloid
leukemia: A national population-based cohort study. J Clin Oncol.
33:3641–3649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Samra B, Richard-Carpentier G, Kadia TM,
Ravandi F, Daver N, DiNardo CD, Issa GC, Bose P, Konopleva MY,
Yilmaz M, et al: Characteristics and outcomes of patients with
therapy-related acute myeloid leukemia with normal karyotype. Blood
Cancer J. 10:472020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kern W, Haferlach T, Schnittger S,
Hiddemann W and Schoch C: Prognosis in therapy-related acute
myeloid leukemia and impact of karyotype. J Clin Oncol.
22:2510–2511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cleven AH, Nardi V, Ok CY, Goswami M, Dal
Cin P, Zheng Z, Iafrate AJ, Abdul Hamid MA, Wang SA and Hasserjian
RP: High p53 protein expression in therapy-related myeloid
neoplasms is associated with adverse karyotype and poor outcome.
Mod Pathol. 28:552–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liehr T: International system for human
cytogenetic or cytogenomic nomenclature (ISCN): Some thoughts.
Cytogenet Genome Res. 161:223–224. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eisfeld AK, Mrózek K, Kohlschmidt J,
Nicolet D, Orwick S, Walker CJ, Kroll KW, Blachly JS, Carroll AJ,
Kolitz JE, et al: The mutational oncoprint of recurrent cytogenetic
abnormalities in adult patients with de novo acute myeloid
leukemia. Leukemia. 31:2211–2218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dohner H, Estey E, Grimwade D, Amadori S,
Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA,
et al: Diagnosis and management of AML in adults: 2017 ELN
recommendations from an international expert panel. Blood.
129:424–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maung SW, Burke C, Hayde J, Walshe J,
McDermott R, Desmond R, McHugh J and Enright H: A review of
therapy-related myelodysplastic syndromes and acute myeloid
leukaemia (t-MDS/AML) in Irish patients: A single centre
experience. Hematology. 22:341–346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ossenkoppele G and Montesinos P:
Challenges in the diagnosis and treatment of secondary acute
myeloid leukemia. Crit Rev Oncol Hematol. 138:6–13. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McNerney ME, Godley LA and Le Beau MM:
Therapy-related myeloid neoplasms: When genetics and environment
collide. Nat Rev Cancer. 17:513–527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vicente-Ayuso MDC, Garcia-Roa M,
González-Fernández A, Álvarez-Carmona AM, Benavente-Cuesta C,
Mateo-Morales M, Pérez-López C, Peña-Cortijo A, Zarzuela MP,
Gutiérrez L and Martínez-Martínez R: Therapy-related myeloid
neoplasms as a concerning complication in acute promyelocytic
leukemia. Hematol Rep. 9:72042017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thakral B and Muzzafar T: Diagnosing
therapy-related acute myeloid leukemia with 8% blasts in bone
marrow with concomitant plasma cell myeloma. Blood. 130:2312017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Menghrajani K, Zhang Y, Famulare C, Devlin
SM and Tallman MS: Acute myeloid leukemia with 11q23
rearrangements: A study of therapy-related disease and therapeutic
outcomes. Leuk Res. 98:1064532020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lindsley RC, Mar BG, Mazzola E, Grauman
PV, Shareef S, Allen SL, Pigneux A, Wetzler M, Stuart RK, Erba HP,
et al: Acute myeloid leukemia ontogeny is defined by distinct
somatic mutations. Blood. 125:1367–1376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Higgins A and Shah MV: Genetic and genomic
landscape of secondary and therapy-related acute myeloid leukemia.
Genes (Basel). 11:7492020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Renella R, Verkooijen HM, Fioretta G,
Vlastos G, Kurtz J, Sappino AP, Schäfer P, Neyroud-Caspar I and
Bouchardy C: Increased risk of acute myeloid leukaemia after
treatment for breast cancer. Breast. 15:614–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong TN, Ramsingh G, Young AL, Miller CA,
Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, et
al: Role of TP53 mutations in the origin and evolution of
therapy-related acute myeloid leukaemia. Nature. 518:552–555. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dayyani F, Kantarjian H, O'Brien S, Pierce
S, Jones D, Faderl S, Garcia-Manero G, Cortes J and Ravandi F:
Outcome of therapy-related acute promyelocytic leukemia with or
without arsenic trioxide as a component of frontline therapy.
Cancer. 117:110–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stein EM, DiNardo CD, Pollyea DA, Fathi
AT, Roboz GJ, Altman JK, Stone RM, DeAngelo DJ, Levine RL, Flinn
IW, et al: Enasidenib in mutant IDH2 relapsed or refractory acute
myeloid leukemia. Blood. 130:722–731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishiyama T, Ishikawa Y, Kawashima N,
Akashi A, Adachi Y, Hattori H, Ushijima Y and Kiyoi H: Mutation
analysis of therapy-related myeloid neoplasms. Cancer Genet.
222–223. 38–45. 2018.PubMed/NCBI
|
|
25
|
Imagawa J, Harada Y, Shimomura T, Tanaka
H, Okikawa Y, Hyodo H, Kimura A and Harada H: Clinical and genetic
features of therapy-related myeloid neoplasms after chemotherapy
for acute promyelocytic leukemia. Blood. 116:6018–6022. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rashidi A and Fisher SI: Therapy-related
acute promyelocytic leukemia: A systematic review. Med Oncol.
30:6252013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joannides M, Mays AN, Mistry AR, Hasan SK,
Reiter A, Wiemels JL, Felix CA, Coco FL, Osheroff N, Solomon E and
Grimwade D: Molecular pathogenesis of secondary acute promyelocytic
leukemia. Mediterr J Hematol Infect Dis. 3:e20110452011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dissing M, Le Beau MM and
Pedersen-Bjergaard J: Inversion of chromosome 16 and uncommon
rearrangements of the CBFB and MYH11 genes in therapy-related acute
myeloid leukemia: Rare events related to DNA-topoisomerase II
inhibitors? J Clin Oncol. 16:1890–1896. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imamura T, Taga T, Takagi M, Kawasaki H,
Koh K, Taki T, Adachi S, Manabe A and Ishida Y; Leukemia/Lymphoma
Committee; Japanese Society of Pediatric Hematology Oncology
(JSPHO), . Nationwide survey of therapy-related leukemia in
childhood in Japan. Int J Hematol. 108:91–97. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Metafuni E, Chiusolo P, Laurenti L, Sorà
F, Giammarco S, Bacigalupo A, Leone G and Sica S: Allogeneic
hematopoietic stem cell transplantation in therapy-related myeloid
neoplasms (t-MN) of the adult: Monocentric observational study and
review of the literature. Mediterr J Hematol Infect Dis.
10:e20180052018. View Article : Google Scholar : PubMed/NCBI
|
